Optiscan Imaging Limited (ASX:OIL)

Market Cap	109.64M +9.4%
Revenue (ttm)	2.44M -50.9%
Net Income	-7.33M
EPS	-0.01
Shares Out	1.04B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	206,707
Average Volume	156,899
Open	0.1070
Previous Close	0.1050
Day's Range	0.1070 - 0.1100
52-Week Range	0.0790 - 0.1500
Beta	0.09
RSI	46.49
Earnings Date	May 25, 2026

About Optiscan Imaging

Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinica...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1994
• Employees: 9
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OIL

Financial Performance

In fiscal year 2025, Optiscan Imaging's revenue was 3.72 million, an increase of 24.72% compared to the previous year's 2.99 million. Losses were -6.31 million, 4.15% more than in 2024.